Advanced Medical Solutions Grp PLC Director/PDMR Shareholding (8282B)

TIDMAMS

RNS Number : 8282B

Advanced Medical Solutions Grp PLC

06 April 2017

 
 
     5 April 2017 
 

Advanced Medical Solutions Group plc

("AMS", the "Company" or the "Group")

Director/PDMR and PCA Shareholding

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), a leading developer and manufacturer of advanced products for the global surgical and advanced wound care markets, announces that it was notified on 4 April 2017 that on the same day, Chris Meredith, who is a Director and PDMR, had transferred 5,900 Ordinary Shares of 5p held in the name of Platform Securities Nominees Limited ("Nominee") to a self-invested personal pension ("SIPP") held in his name.

The Company was also informed at the same time, that on 4 April 2017 Chris Meredith had transferred 4,780 Ordinary Shares of 5p held in the name of the Nominee to an Individual Savings Account ("ISA") held in the name of Ingrid Meredith, the wife of Chris Meredith. The number of shares held by Chris Meredith and the beneficial ownership of the shares remains unchanged. Both transactions are part of normalised tax planning. The transfers are summarised below:

 
 Director     Number         Price       Number         Price           Number         Price 
               of Ordinary    per         of Ordinary    paid            of Ordinary    paid 
               Shares         Ordinary    Shares         per Ordinary    Shares         per Ordinary 
               sold           Share       purchased      Share           purchased      Share 
               from           sold        by SIPP        by SIPP         by ISA         by ISA 
               Nominee 
-----------  -------------  ----------  -------------  --------------  -------------  -------------- 
 Chris 
  Meredith    5,900          249.25p     5,900          249.50p         -              - 
-----------  -------------  ----------  -------------  --------------  -------------  -------------- 
 Chris 
  Meredith    4,780          249.25p     -              -               4,780          249.50p 
-----------  -------------  ----------  -------------  --------------  -------------  -------------- 
 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 
 1.   Details of the person discharging managerial 
       responsibilities/person closely associated 
---  --------------------------------------------------------------- 
 a)   Name: Chris Meredith 
---  --------------------------------------------------------------- 
 2.   Reason for the notification 
---  --------------------------------------------------------------- 
 a)   Position/status: Director/PDMR 
---  --------------------------------------------------------------- 
 b)   Initial notification/Amendment: Initial 
       Notification 
---  --------------------------------------------------------------- 
 3.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
---  --------------------------------------------------------------- 
 a)   Name: Advanced Medical Solutions Group 
       plc 
---  --------------------------------------------------------------- 
 b)   LEI: 213800HJP6OWOSZI1L74 
---  --------------------------------------------------------------- 
 4.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transactions 
       have been conducted 
---  --------------------------------------------------------------- 
 a)   Description of the financial instrument, 
       type of instrument: Ordinary Shares of 
       5p 
       Identification code: GB0004536594 
---  --------------------------------------------------------------- 
 b)      Nature of the transactions: 
           *    Transfer of 5,900 Ordinary Shares of 5p held in the 
                name the Nominee to a SIPP held in the name of Chris 
                Meredith 
---  --------------------------------------------------------------- 
 c)   Price(s) and volume(s): 
       Sale of shares: Price(s)          Volume(s) 
       ----------------  ---------- 
        Sale of shares 
         from Nominee 
         holding at 
         249.25p per 
         share            5,900 
       ----------------  ---------- 
        Purchase 
         by SIPP at 
         249.50p per 
         share            5,900 
       ----------------  ---------- 
---  --------------------------------------------------------------- 
 d)   Aggregated information: (Relates to those 
       shares sold only) 
       Aggregated volume: 5,900 
       Aggregated price: 249.25p 
---  --------------------------------------------------------------- 
 e)   Date of the transaction: 04/04/2017 
---  --------------------------------------------------------------- 
 f)   Place of the transaction: London Stock 
       Exchange, AIM Market (XLON) 
---  --------------------------------------------------------------- 
 
 
 1.   Details of the person discharging managerial 
       responsibilities/person closely associated 
---  ---------------------------------------------------------------- 
 a)   Name: Chris Meredith 
---  ---------------------------------------------------------------- 
 2.   Reason for the notification 
---  ---------------------------------------------------------------- 
 a)   Position/status: Director/PDMR 
---  ---------------------------------------------------------------- 
 b)   Initial notification/Amendment: Initial 
       Notification 
---  ---------------------------------------------------------------- 
 3.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
---  ---------------------------------------------------------------- 
 a)   Name: Advanced Medical Solutions Group 
       plc 
---  ---------------------------------------------------------------- 
 b)   LEI: 213800HJP6OWOSZI1L74 
---  ---------------------------------------------------------------- 
 4.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transactions 
       have been conducted 
---  ---------------------------------------------------------------- 
 a)   Description of the financial instrument, 
       type of instrument: Ordinary Shares of 
       5p 
       Identification code: GB0004536594 
---  ---------------------------------------------------------------- 
 b)      Nature of the transactions: 
           *    Transfer of 4,780 Ordinary Shares of 5p held in the 
                name the Nominee to an ISA held in the name of Ingrid 
                Meredith 
---  ---------------------------------------------------------------- 
 c)   Price(s) and volume(s): 
       Sale of shares: Price(s)          Volume(s) 
       ----------------  ---------- 
        Sale of shares 
         from Nominee 
         holding at 
         249.25p per 
         share            4,780 
       ----------------  ---------- 
        Purchase 
         by ISA at 
         249.50p per 
         share            4,780 
       ----------------  ---------- 
---  ---------------------------------------------------------------- 
 d)   Aggregated information: (Relates to those 
       shares sold only) 
       Aggregated volume: 4,780 
       Aggregated price: 249.25p 
---  ---------------------------------------------------------------- 
 e)   Date of the transaction: 04/04/2017 
---  ---------------------------------------------------------------- 
 f)   Place of the transaction: London Stock 
       Exchange, AIM Market (XLON) 
---  ---------------------------------------------------------------- 
 

- End -

For further information, please visit www.admedsol.com or contact:

 
 Advanced Medical Solutions Group                Tel: +44 (0) 
  plc                                             1606 545508 
 Chris Meredith, Chief Executive 
  Officer 
  Mary Tavener, Chief Financial 
  Officer 
 
 Consilium Strategic Communications              Tel: +44 (0) 
                                                 20 3709 5700 
 Mary-Jane Elliott / Jonathan         [e-mail] 
  Birt / Matthew Neal / Hendrik 
  Thys 
 
 Investec Bank PLC (NOMAD & Broker)              Tel: +44 (0) 
                                                 20 7597 5970 
 Daniel Adams / Patrick Robb 
 

About Advanced Medical Solutions Group plc - see www.admedsol.com

AMS is a world-leading independent developer and manufacturer of innovative and technologically advanced products for the global surgical and advanced wound care markets, focused on quality outcomes for patients and value for payors. AMS has a wide range of wound care products that include silver alginates, alginates, foams, tissue adhesives, sutures and haemostats, which it sells under white label as well as its own brand ActivHeal(R) , and surgical tissue adhesives, sutures and haemostats, which markets under its own brands; LiquiBand(R) and RESORBA(R) .

AMS's products, manufactured out of two sites in the UK, one in the Netherlands, two in Germany and one in the Czech Republic, are sold in more than 70 countries via a network of multinational or regional partners and distributors, as well as via AMS's own direct sales forces in the UK, Germany, the Czech Republic and Russia. Established in 1991, the Company has 600 employees. For more information, please see www.admedsol.com.

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHBDGDSDDGBGRL

(END) Dow Jones Newswires

April 06, 2017 08:23 ET (12:23 GMT)